chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 5.0
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from an office manager and refers to a 5 year-old patient of unknown gender. There was no information about patient's concomitant medications, concurrent conditions or pertinent medical history reported. On 01-NOV-2016, the patient was vaccinated with the first improperly stored dose of VARIVAX, lot number M027885 with an expiration date on 30-JUN-2018 (dose, route and anatomical location was not reported) for prophylaxis. The vaccine was exposed to temperature of 7.7 Fahrenheit (F) during 24 hours. There was no previous temperature excursion. No adverse effects were reported. No data logger was involved. This is one of several reports from the same source. Additional information has been requested.; Sender's Comments: US-009507513-1704USA004460: US-009507513-1704USA004461: US-009507513-1704USA004462: US-009507513-1704USA004463: US-009507513-1704USA004464: US-009507513-1704USA004465: US-009507513-1704USA004466: US-009507513-1704USA004467: US-009507513-1704USA004468: US-009507513-1704USA004469: US-009507513-1704USA004470: US-009507513-1704USA004471: US-009507513-1704USA004472: US-009507513-1704USA004473: US-009507513-1704USA004474: US-009507513-1704USA004475: US-009507513-1704USA004476: US-009507513-1704USA004477: US-009507513-1704USA004478: US-009507513-1704USA004479: US-009507513-1704USA004481: US-009507513-1704USA004482: US-009507513-1704USA004483: US-009507513-1704USA004484: US-009507513-1704USA004485: US-009507513-1704USA004486: US-009507513-1704USA004487: US-009507513-1704USA004488: US-009507513-1704USA004489: US-009507513-1704USA004490: US-009507513-1704USA004491: US-009507513-1704USA004492: US-009507513-1704USA004493: US-009507513-1704USA004494: US-009507513-1704USA004495: US-009507513-1704USA004496: US-009507513-1704USA004497: US-009507513-1704USA004498: US-009507513-1704USA004499: US-009507513-1704USA004500: US-009507513-1704USA004501: US-009507513-1704USA004502: US-009507513-1704USA004503: US-009507513-1704USA004504: US-009507513-1704USA004505: US-009507513-1704USA004506: US-009507513-1704USA004507: US-009507513-1704USA004508: US-009507513-1704USA004509: US-009507513-1704USA004510: US-009507513-1704USA004511: US-009507513-1704USA004512: US-009507513-1704USA004513:US-009507513-1704USA004514: US-009507513-1704USA004515: US-009507513-1704USA004516: US-009507513-1704USA004517:
Age: 1.92
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from an office manager and refers to a 23 month old patient of unknown gender. There was no information about patient's concomitant medications and pertinent medical history reported. On 06-DEC-2016, the patient was vaccinated with the first improperly stored dose of VARIVAX, lot number M027885 with expiration date 30-JUN-2018 (dose, route and anatomical location was not reported) for prophylaxis. The vaccine was exposed to temperature of 7.7 Fahrenheit (F) during 24 hours. There was no previous temperature excursion. No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested.; Sender's Comments:  US-009507513-1612USA007652: US-009507513-1704USA004460: US-009507513-1704USA004461: US-009507513-1704USA004462: US-009507513-1704USA004463: US-009507513-1704USA004464: US-009507513-1704USA004465: US-009507513-1704USA004466: US-009507513-1704USA004467: US-009507513-1704USA004468: US-009507513-1704USA004469: US-009507513-1704USA004470: US-009507513-1704USA004471: US-009507513-1704USA004472: US-009507513-1704USA004473: US-009507513-1704USA004474: US-009507513-1704USA004475: US-009507513-1704USA004476: US-009507513-1704USA004477: US-009507513-1704USA004478: US-009507513-1704USA004479: US-009507513-1704USA004480: US-009507513-1704USA004481: US-009507513-1704USA004482: US-009507513-1704USA004483: US-009507513-1704USA004484: US-009507513-1704USA004485: US-009507513-1704USA004486: US-009507513-1704USA004487: US-009507513-1704USA004488: US-009507513-1704USA004489: US-009507513-1704USA004490: US-009507513-1704USA004491: US-009507513-1704USA004492: US-009507513-1704USA004493: US-009507513-1704USA004494: US-009507513-1704USA004495: US-009507513-1704USA004496: US-009507513-1704USA004497: US-009507513-1704USA004498: US-009507513-1704USA004499: US-009507513-1704USA004500: US-009507513-1704USA004501: US-009507513-1704USA004502: US-009507513-1704USA004503: US-009507513-1704USA004504: US-009507513-1704USA004505: US-009507513-1704USA004506: US-009507513-1704USA004508: US-009507513-1704USA004509: US-009507513-1704USA004510: US-009507513-1704USA004511: US-009507513-1704USA004512: US-009507513-1704USA004513: US-009507513-1704USA004514: US-009507513-1704USA004515: US-009507513-1704USA004516: US-009507513-1704USA004517:
Age: 4.0
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from an office manager and refers to a 4-year-old patient of unknown gender. There was no information about patient's concomitant medications and pertinent medical history reported. On 06-DEC-2016, the patient was vaccinated with the first improperly stored dose of VARIVAX, lot number M027885 with expiration date 30-JUN-2018 (dose, route and anatomical location was not reported) for prophylaxis. The vaccine was exposed to temperature of 7.7 Fahrenheit (F) during 24 hours. There was no previous temperature excursion. No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested.; Sender's Comments:  US-009507513-1612USA007652: US-009507513-1704USA004460: US-009507513-17 4USA004461:US-009507513-1704USA004462: US-009507513-1704USA004463: US-009507513-1704USA004464: US-009507513-1704USA004465: US-009507513-1704USA004466: US-009507513-1704USA004467: US-009507513-1704USA004468: US-009507513-1704USA004469: US-009507513-1704USA004470: US-009507513-1704USA004471: US-009507513-1704USA004472: US-009507513-1704USA004473: US-009507513-1704USA004474: US-009507513-1704USA004475: US-009507513-1704USA004476: US-009507513-1704USA004477: US-009507513-1704USA004478: US-009507513-1704USA004479: US-009507513-1704USA004480: US-009507513-1704USA004481: US-009507513-1704USA004482: US-009507513-1704USA004483: US-009507513-1704USA004484: US-009507513-1704USA004485: US-009507513-1704USA004486: US-009507513-1704USA004487: US-009507513-1704USA004488: US-009507513-1704USA004489: US-009507513-1704USA004490: US-009507513-1704USA004491: US-009507513-1704USA004492: US-009507513-1704USA004493: US-009507513-1704USA004494: US-009507513-1704USA004495: US-009507513-1704USA004496: US-009507513-1704USA004497: US-009507513-1704USA004498: US-009507513-1704USA004499: US-009507513-1704USA004500: US-009507513-1704USA004501: US-009507513-1704USA004502: US-009507513-1704USA004503: US-009507513-1704USA004504: US-009507513-1704USA004505: US-009507513-1704USA004506: US-009507513-1704USA004507: US-009507513-1704USA004509: US-009507513-1704USA004510: US-009507513-1704USA004511: US-009507513-1704USA004512: US-009507513-1704USA004513: US-009507513-1704USA004514: US-009507513-1704USA004515: US-009507513-1704USA004516: US-009507513-1704USA004517:
Age: 4.0
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from an office manager and refers to a 4-year-old patient of unknown gender. There was no information about patient's concomitant medications and pertinent medical history reported. On 07-DEC-2016, the patient was vaccinated with the first improperly stored dose of VARIVAX, lot number M027885 with expiration date 30-JUN-2018 (dose, route and anatomical location was not reported) for prophylaxis. The vaccine was exposed to temperature of 7.7 Fahrenheit (F) during 24 hours. There was no previous temperature excursion. No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested.; Sender's Comments:  US-009507513-1612USA007652: US-009507513-1704USA004460: US-009507513-1704USA004461: US-009507513-1704USA004462: US-009507513-1704USA004463: US-009507513-1704USA004464: US-009507513-1704USA004465: US-009507513-1704USA004466: US-009507513-1704USA004467: US-009507513-1704USA004468: US-009507513-1704USA004469: US-009507513-1704USA004470: US-009507513-1704USA004471: US-009507513-1704USA004472: US-009507513-1704USA004473: US-009507513-1704USA004474: US-009507513-1704USA004475: US-009507513-1704USA004476: US-009507513-1704USA004477: US-009507513-1704USA004478: US-009507513-1704USA004479: US-009507513-1704USA004480: US-009507513-1704USA004481: US-009507513-1704USA004482: US-009507513-1704USA004483: US-009507513-1704USA004484: US-009507513-1704USA004485: US-009507513-1704USA004486: US-009507513-1704USA004487: US-009507513-1704USA004488: US-009507513-1704USA004489: US-009507513-1704USA004490: US-009507513-1704USA004491: US-009507513-1704USA004492: US-009507513-1704USA004493: US-009507513-1704USA004494: US-009507513-1704USA004495: US-009507513-1704USA004496: US-009507513-1704USA004497: US-009507513-1704USA004498: US-009507513-1704USA004499: US-009507513-1704USA004500: US-009507513-1704USA004501: US-009507513-1704USA004502: US-009507513-1704USA004503: US-009507513-1704USA004504: US-009507513-1704USA004505: US-009507513-1704USA004506: US-009507513-1704USA004507: US-009507513-1704USA004508: US-009507513-1704USA004510: US-009507513-1704USA004511: US-009507513-1704USA004512: US-009507513-1704USA004513: US-009507513-1704USA004514: US-009507513-1704USA004515: US-009507513-1704USA004516: US-009507513-1704USA004517:
Age: 1.17
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from an office manager and refers to a 14 month old patient of unknown gender. There was no information about patient's concomitant medications and pertinent medical history reported. On 07-DEC-2016, the patient was vaccinated with the first improperly stored dose of VARIVAX, lot number M027885 with expiration date 30-JUN-2018 (dose, route and anatomical location was not reported) for prophylaxis. The vaccine was exposed to temperature of 7.7 Fahrenheit (F) during 24 hours. There was no previous temperature excursion. No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested.; Sender's Comments:  US-009507513-1612USA007652: US-009507513-1704USA004460: US-009507513-1704USA004461: US-009507513-1704USA004462: US-009507513-1704USA004463: US-009507513-1704USA004464: US-009507513-1704USA004465: US-009507513-1704USA004466: US-009507513-1704USA004467: US-009507513-1704USA004468: US-009507513-1704USA004469: US-009507513-1704USA004470: US-009507513-1704USA004471: US-009507513-1704USA004472: US-009507513-1704USA004473: US-009507513-1704USA004474: US-009507513-1704USA004475: US-009507513-1704USA004476: US-009507513-1704USA004477: US-009507513-1704USA004478: US-009507513-1704USA004479: US-009507513-1704USA004480: US-009507513-1704USA004481: US-009507513-1704USA004482: US-009507513-1704USA004483: US-009507513-1704USA004484: US-009507513-1704USA004485: US-009507513-1704USA004486: US-009507513-1704USA004487: US-009507513-1704USA004488: US-009507513-1704USA004489: US-009507513-1704USA004490: US-009507513-1704USA004491: US-009507513-1704USA004492: US-009507513-1704USA004493: US-009507513-1704USA004494: US-009507513-1704USA004495: US-009507513-1704USA004496: US-009507513-1704USA004497: US-009507513-1704USA004498: US-009507513-1704USA004499: US-009507513-1704USA004500: US-009507513-1704USA004501: US-009507513-1704USA004502: US-009507513-1704USA004503: US-009507513-1704USA004504: US-009507513-1704USA004505: US-009507513-1704USA004506: US-009507513-1704USA004507: US-009507513-1704USA004508: US-009507513-1704USA004509: US-009507513-1704USA004511: US-009507513-1704USA004512: US-009507513-1704USA004513: US-009507513-1704USA004514: US-009507513-1704USA004515: US-009507513-1704USA004516: US-009507513-1704USA004517:
Age: 4.0
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from an office manager and refers to a 4-year-old patient of unknown gender. There was no information about patient's concomitant medications and pertinent medical history reported. On 08-DEC-2016, the patient was vaccinated with the first improperly stored dose of VARIVAX, lot number M027885 with expiration date 30-JUN-2018 (dose, route and anatomical location was not reported) for prophylaxis. The vaccine was exposed to temperature of 7.7 Fahrenheit (F) during 24 hours. There was no previous temperature excursion. No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested.; Sender's Comments:  US-009507513-1612USA007652: US-009507513-1704USA004460: US-009507513-1704USA004461: US-009507513-1704USA004462: US-009507513-1704USA004463: US-009507513-1704USA004464: US-009507513-1704USA004465: US-009507513-1704USA004466: US-009507513-1704USA004467: US-009507513-1704USA004468: US-009507513-1704USA004469: US-009507513-1704USA004470: US-009507513-1704USA004471: US-009507513-1704USA004472: US-009507513-1704USA004473: US-009507513-1704USA004474: US-009507513-1704USA004475: US-009507513-1704USA004476: US-009507513-1704USA004477: US-009507513-1704USA004478: US-009507513-1704USA004479: US-009507513-1704USA004480: US-009507513-1704USA004481: US-009507513-1704USA004482: US-009507513-1704USA004483: US-009507513-1704USA004484: US-009507513-1704USA004485: US-009507513-1704USA004486: US-009507513-1704USA004487: US-009507513-1704USA004488: US-009507513-1704USA004489: US-009507513-1704USA004490: US-009507513-1704USA004491: US-009507513-1704USA004492: US-009507513-1704USA004493: US-009507513-1704USA004494: US-009507513-1704USA004495: US-009507513-1704USA004496: US-009507513-1704USA004497: US-009507513-1704USA004498: US-009507513-1704USA004499: US-009507513-1704USA004500: US-009507513-1704USA004501: US-009507513-1704USA004502: US-009507513-1704USA004503: US-009507513-1704USA004504: US-009507513-1704USA004505: US-009507513-1704USA004506: US-009507513-1704USA004507: US-009507513-1704USA004508: US-009507513-1704USA004509: US-009507513-1704USA004510: US-009507513-1704USA004512: US-009507513-1704USA004513: US-009507513-1704USA004514: US-009507513-1704USA004515: US-009507513-1704USA004516: US-009507513-1704USA004517:
Age: 1.0
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from an office manager and refers to a 12 month old patient of unknown gender. There was no information about patient's concomitant medications and pertinent medical history reported. On 12-DEC-2016, the patient was vaccinated with the first improperly stored dose of VARIVAX, lot number M027885with expiration date 30-JUN-2018 (dose, route and anatomical location was not reported) for prophylaxis. The vaccine was exposed to temperature of 7.7 Fahrenheit (F) during 24 hours. There was no previous temperature excursion. No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested.; Sender's Comments:  US-009507513-1612USA007652: US-009507513-1704USA004460: US-009507513-1704USA004461: US-009507513-1704USA004462: US-009507513-1704USA004463: US-009507513-1704USA004464: US-009507513-1704USA004465: US-009507513-1704USA004466: US-009507513-1704USA004467: US-009507513-1704USA004468: US-009507513-1704USA004469: US-009507513-1704USA004470: US-009507513-1704USA004471: US-009507513-1704USA004472: US-009507513-1704USA004473: US-009507513-1704USA004474: US-009507513-1704USA004475: US-009507513-1704USA004476: US-009507513-1704USA004477: US-009507513-1704USA004478: US-009507513-1704USA004479: US-009507513-1704USA004480: US-009507513-1704USA004481: US-009507513-1704USA004482: US-009507513-1704USA004483: US-009507513-1704USA004484: US-009507513-1704USA004485: US-009507513-1704USA004486: US-009507513-1704USA004487: US-009507513-1704USA004488: US-009507513-1704USA004489: US-009507513-1704USA004490: US-009507513-1704USA004491: US-009507513-1704USA004492: US-009507513-1704USA004493: US-009507513-1704USA004494: US-009507513-1704USA004495: US-009507513-1704USA004496: US-009507513-1704USA004497: US-009507513-1704USA004498: US-009507513-1704USA004499: US-009507513-1704USA004500: US-009507513-1704USA004501: US-009507513-1704USA004502: US-009507513-1704USA004503: US-009507513-1704USA004504: US-009507513-1704USA004505: US-009507513-1704USA004506: US-009507513-1704USA004507: US-009507513-1704USA004508: US-009507513-1704USA004509: US-009507513-1704USA004510: US-009507513-1704USA004511: US-009507513-1704USA004513: US-009507513-1704USA004514: US-009507513-1704USA004515: US-009507513-1704USA004516: US-009507513-1704USA004517:
Age: 4.0
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect product storage, No adverse event
Clinical narrative: This spontaneous report was received from an office manager and refers to a 4-year-old patient of unknown gender. There was no information about patient's concomitant medications and pertinent medical history reported. On 14-DEC-2016, the patient was vaccinated with the first improperly stored dose of VARIVAX, lot number M027885 with expiration date 30-JUN-2018 (dose, route and anatomical location was not reported) for prophylaxis. The vaccine was exposed to temperature of 7.7 Fahrenheit (F) during 24 hours. There was no previous temperature excursion. No adverse effects were reported. This is one of several reports from the same source. Additional information has been requested.; Sender's Comments:  US-009507513-1612USA007652: US-009507513-1704USA004460: US-009507513-1704USA004461: US-009507513-1704USA004462: US-009507513-1704USA004463: US-009507513-1704USA004464: US-009507513-1704USA004465: US-009507513-1704USA004466: US-009507513-1704USA004467: US-009507513-1704USA004468: US-009507513-1704USA004469: US-009507513-1704USA004470: US-009507513-1704USA004471: US-009507513-1704USA004472: US-009507513-1704USA004473: US-009507513-1704USA004474: US-009507513-1704USA004475: US-009507513-1704USA004476: US-009507513-1704USA004477: US-009507513-1704USA004478: US-009507513-1704USA004479: US-009507513-1704USA004480: US-009507513-1704USA004481: US-009507513-1704USA004482: US-009507513-1704USA004483: US-009507513-1704USA004484: US-009507513-1704USA004485: US-009507513-1704USA004486: US-009507513-1704USA004487: US-009507513-1704USA004488: US-009507513-1704USA004489: US-009507513-1704USA004490: US-009507513-1704USA004491: US-009507513-1704USA004492: US-009507513-1704USA004493: US-009507513-1704USA004494: US-009507513-1704USA004495: US-009507513-1704USA004496: US-009507513-1704USA004497: US-009507513-1704USA004498: US-009507513-1704USA004499: US-009507513-1704USA004500: US-009507513-1704USA004501: US-009507513-1704USA004502: US-009507513-1704USA004503: US-009507513-1704USA004504: US-009507513-1704USA004505: US-009507513-1704USA004506: US-009507513-1704USA004507: US-009507513-1704USA004508: US-009507513-1704USA004509: US-009507513-1704USA004510: US-009507513-1704USA004511: US-009507513-1704USA004512: US-009507513-1704USA004514: US-009507513-1704USA004515: US-009507513-1704USA004516: US-009507513-1704USA004517:
Age: 4.0
Sex: U
Vaccine: MMR
Symptoms: Incorrect route of drug administration
Clinical narrative: Patient was given MMR vaccine IM instead of sub q had audit 1/25/17 and auditor saw patients chart and noticed MMR was given IM and was informed to report it.
Age: 16.0
Sex: F
Vaccine: MNQ
Symptoms: Crying, Rash erythematous, Rash macular
Clinical narrative: Erythematous lacey macular rash on ant. legs. Evanescent crying episode assoc. approximately 1 hr.
Age: 7.0
Sex: U
Vaccine: DTAP
Symptoms: Wrong drug administered
Clinical narrative: Pt was given DTaP and should have been given Tdap.
Age: 0.6
Sex: U
Vaccine: DTAPIPV
Symptoms: Drug administered to patient of inappropriate age, Wrong drug administered
Clinical narrative: 7 month old received KINRIX, instead of Dtap
Age: 16.0
Sex: U
Vaccine: FLUX, MENB
Symptoms: Wrong drug administered
Clinical narrative: "I received an order of hearing, vision and two vaccines for a 16 year patient. So first I did the hearing and the vision than I went to the refrigerator and I got the flu shot and the TRUMENBA instead of MENACTRA and then I went and got the VIS for the meningococcal and the flu shot after that I gave the vaccines and realized my mistaken after I have administered the vaccine and I was ready to chart. I notified the doctor and the attending. Than I notified my charge nurse."
Age: 2.0
Sex: U
Vaccine: FLU4
Symptoms: Incorrect dose administered
Clinical narrative: Gave wrong dosage.
Age: 8.0
Sex: U
Vaccine: FLU4
Symptoms: Drug administered to patient of inappropriate age, Wrong drug administered
Clinical narrative: Grabbed wrong dosage of vaccine. Age of patient at time of event: 8 years 8 months.
Age: 5.0
Sex: U
Vaccine: FLU4
Symptoms: Underdose
Clinical narrative: Wrong dose was given.
Age: 6.0
Sex: U
Vaccine: FLU4, TDAP
Symptoms: Drug administered to patient of inappropriate age, Wrong drug administered
Clinical narrative: TDaP given instead of DTaP. Patient received 4 doses of DTaP all at the appropriate times. The 5th dose, TDaP was inadvertently given when the patient should have received the final 5th dose of DTaP. Intradermal flu shot given instead of age appropriate flu shot. Patient inadvertently received intradermal 0.1ML ID FLUZONE instead of VFC-Child age appropriate 0.5ML IM FLUARIX.
Age: 0.65
Sex: U
Vaccine: RV5
Symptoms: Extra dose administered
Clinical narrative: A 4th dose of ROTATEQ was given, as our EMR and electronic records did not match up, as electronic records had an upgrade this weekend. The 4th dose, however, was given past the 32 week max at 34 weeks and 2 days.
Age: 0.8
Sex: U
Vaccine: HEP, PNC13
Symptoms: Extra dose administered
Clinical narrative: I informed the parents immediately of the error when I discovered it and apologized. My clerical staff and I have developed a workaround to this problem by using paper records generated from the original system interface before system2 went live. We are comparing all currently scheduled clients' system2 records with the paper records of IZs and entering IZs that system2 lacks.
Age: 13.0
Sex: U
Vaccine: MNQ
Symptoms: Expired product administered
Clinical narrative: This expired vaccine was administered. Age of patient at time of event: 13 years.
Age: 56.0
Sex: U
Vaccine: VARCEL, VARZOS
Symptoms: Wrong drug administered
Clinical narrative: VARIVAX was administered to an adult patient instead of ZOSTAVAX.
Age: 0.3
Sex: U
Vaccine: DTAPHEPBIP, DTAPIPVHIB
Symptoms: Wrong drug administered
Clinical narrative: 4 month old infant given both PEDIARIX and PENTACEL at same visit. Should have given PREVNAR. Age of patient at time of event: 4 months. Age of patient at time of event: 4 months.
Age: 65.0
Sex: U
Vaccine: FLU4, PNC13
Symptoms: Wrong drug administered
Clinical narrative: Patient received influenza vaccine instead of PREVNAR 13.
Age: 16.0
Sex: U
Vaccine: MMRV, VARCEL
Symptoms: Wrong drug administered
Clinical narrative: Patient was suppose to get MMR and Varicella, but instead got both PROQUAD (which contains MMR and varicella) and a separate Varicella vaccine. PROQUAD is stored in freezer next to varicella. MMR is stored in different refrigerator. Staff member grabbed a PROQUAD and varicella, instead of MMR.
Age: 4.0
Sex: U
Vaccine: DTAPHEPBIP
Symptoms: Wrong drug administered
Clinical narrative: Wrong vaccine given, provider ordered KINRIX and PEDIARIX was given by MA.
Sex: U
Vaccine: TDAP
Symptoms: Drug administered to patient of inappropriate age, Wrong drug administered
Clinical narrative: A newborn baby, less than 6 hours old, was inadvertently given a dose of Tdap in the hospital instead of the birth dose of Hepatitis B vaccine.
Age: 1.0
Sex: U
Vaccine: MMR
Symptoms: Expired product administered, No adverse event
Clinical narrative: Medical assistant accidentally administered an expired vaccine. Pt had no adverse reaction. Counseled MA on importance of checking dates prior to administration of vaccines. Made a general reminder on importance of checking vaccine 5 rights and expiration dates today at huddle.
Age: 60.0
Sex: F
Vaccine: MMR
Symptoms: Dizziness, Dysphagia, Dyspnoea
Clinical narrative: Team member received MMR vaccine. Complain of difficulty swallowing shortness of breath feeling lightheaded.
Age: 14.0
Sex: F
Vaccine: HPV9
Symptoms: Crying, Fatigue, Headache, Injection site pain, Oropharyngeal pain
Clinical narrative: Started with pain at injection site then headache in evening. The following morning, continued headaches, mild elevation in temp. (98.8) and tiredness. By the afternoon the day after the injection: fever 99.8F, headache, sore throat, continued tiredness, weepiness.
Age: 14.0
Sex: F
Vaccine: HPV9
Symptoms: Pyrexia
Clinical narrative: Started with pain at injection site then headache in evening. The following morning, continued headaches, mild elevation in temp. (98.8) and tiredness. By the afternoon the day after the injection: fever 99.8F, headache, sore throat, continued tiredness, weepiness.
Age: 22.0
Sex: F
Vaccine: HEPA
Symptoms: Drug administered to patient of inappropriate age, Wrong drug administered
Clinical narrative: Patient was in Clinic for appointment, administrated HEP A for pediatric instead of Adult dose. Called CDC for further advice for valid or invalid dosing.
Age: 1.25
Sex: M
Vaccine: DTAPHEPBIP, HEPA, HIBV, MMR, PNC13, VARCEL
Symptoms: Petechiae, Rash
Clinical narrative: Mom stated that patient went home, ate, and napped. Pt woke up from nap and mom noted a rash to his face. Mom returned to the clinic to have child evaluated. Petechial rash noted around eyes, to cheeks, and a small area of the chin. Rash not noted anywhere else on the patient's body. Physician did assess patient. No signs/symptoms of distress noted.
Age: 27.0
Sex: U
Vaccine: MMRV
Symptoms: Expired product administered
Clinical narrative: The patient presented with a script for MMR and chicken pox vaccines from her provider. She had been informed on the phone that we stocked them both. When she arrived, she was told that we did not have them both, but that we stocked a combo vaccine that would cover both vaccines. I was not the pharmacist who communicated with the patient or the provider. After administering the vaccine to the patient, I realized when completing the paperwork that the vaccine that I had just given came from an expired lot.
Age: 1.0
Sex: U
Vaccine: MMRV, VARCEL
Symptoms: Product packaging confusion, Wrong drug administered
Clinical narrative: An order was placed for MMR and Varicella, patient was given Varicella and PROQUAD. Vials need to be more distinguishable to avoid confusion.
Age: 0.3
Sex: U
Vaccine: DTAPIPVHIB
Symptoms: Expired product administered
Clinical narrative: Patient came in for 4 month vaccines and was given an expired PENTACEL.
Age: 4.0
Sex: U
Vaccine: HIBV
Symptoms: Extra dose administered, Wrong drug administered
Clinical narrative: A patient came in to receive a Hepatitis A vaccine, among others. In the process of drawing up the vaccines, a PEDVAXHib was pulled from the fridge instead of the Hepatitis A and was administered to the Pt. In result, the Pt. now has an extra dose of PEDVAXHib on his vaccine record and is still in need of a Hepatitis A vaccine. Age of patient at time of event:  4 years 8 days.
Age: 7.0
Sex: U
Vaccine: MNQ
Symptoms: Drug administered to patient of inappropriate age
Clinical narrative: Child came in on 01/06/2017, with a birthdate which mom verified. On a subsequent visit 02/16/2017 it was discovered the date of birth was wrong. Child received a dose of MENACTRA before it was due.
Age: 10.0
Sex: U
Vaccine: MNQ, TDAP
Symptoms: Drug administered to patient of inappropriate age
Clinical narrative: Patient in 2.9.17 for CPE. Per staff provider gave okay to administer vaccine for 10 yrs. 11 months age. Age of patient at time of event: 10 years 11 months. Type of Event: Wrong age (patient not correct age for vaccine given).
Age: 14.0
Sex: U
Vaccine: MMR, MMRV
Symptoms: Extra dose administered
Clinical narrative: Patient arrived to clinic for other complaints include need for MMR as the school system has requested patients prove they have had all MMR vaccinations. We were unable to prove patient had received vaccines therefore vaccinated child per request by school district.
Age: 36.0
Sex: U
Vaccine: HEP
Symptoms: Drug administered to patient of inappropriate age
Clinical narrative: Adult client given pediatric Hepatitis B vaccine. Contacted state immunization dept. who advised to contact client to return same day if possible and given second dose to make full adult dose. Client contacted; returned to clinic; situation explained; consented and given second pediatric dose. Age of patient at time of event: 36 years.
Age: 0.3
Sex: F
Vaccine: DTAPIPV
Symptoms: Drug administered to patient of inappropriate age
Clinical narrative: A four-month-old female was escorted to clinic w/parents on 11/28/2016. Dr ordered standard 4 month vaccines. Patient was given a combination vaccine for KINRIX. KINRIX is indicated for 4-6 year-old age group. Error was identified when patient returned to clinic on 2/17/2017 for well child check and 6 month vaccines per CDC recommended schedule. Vaccines for program was notified by RN for guidance. Center for Disease Control contacted RN with recommendation to give scheduled 6 months vaccines and report incident to VAERS. Patient was vaccinated on 2/17/2017. WWC revealed growth and development WNL. Parents were not apprised the information of information at this time pending further investigation.
Age: 18.0
Sex: U
Vaccine: HEP
Symptoms: Expired product administered, No adverse event
Clinical narrative: 18 year old patient came into office to restart Hepatitis B series. After administering vaccine it was found the lot had expired 10/2016. the patient had no adverse reactions. Age of patient at time of event: 18 years.
Age: 9.0
Sex: U
Vaccine: DTAPHEPBIP, MNQ
Symptoms: Drug administered to patient of inappropriate age
Clinical narrative: Healthy patient without immunization records, needing to start catch up immunizations, given PEDIARIX and MENACTRA at age 9.
Age: 1.2
Sex: U
Vaccine: MMRV, VARCEL
Symptoms: Extra dose administered
Clinical narrative: 15 month old child was inadvertently given the MMRV vaccine as well as the Varicella vaccine.
Age: 1.3
Sex: U
Vaccine: DTAPIPV
Symptoms: Drug administered to patient of inappropriate age, No adverse event
Clinical narrative: 16 month old patient needing catch up shots presented up to date on Hep B but needing DTaP and IPV. Provider asked nurse what combo vaccines were available for patient. Nurse replied KINRIX. Provider did not confirm appropriate age for KINRIX and ordered KINRIX. Nurse administered KINRIX. Patient should have either gotten PEDIARIX and an extra dose of Hep B or separate DTaP and IPV shots given age. No adverse reaction was noted. Our pharmacist called company that manufactures KINRIX and confirmed that KINRIX can count as dose of both DTaP and IPV for child. Parent was notified. It would be nice to see KINRIX approved for a wider age range. Age of patient at time of event: 16 months 20 days.
Age: 60.0
Sex: U
Vaccine: HEPA
Symptoms: Drug administered to patient of inappropriate age, Wrong drug administered
Clinical narrative: Adult given a pediatric dose of HAVRIX instead of the adult dose. Age of patient at time of event: 60 years.
Age: 0.3
Sex: U
Vaccine: FLU4
Symptoms: Drug administered to patient of inappropriate age
Clinical narrative: Patient was 3 months old and received 0.25 mL dose of Influenza vaccine.
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: 63 year old female patient seen on 2/16/17 stated she had not had her zoster vaccination. After administration of ZOSTAVAX, staff member went to enter it in system and noted the patient had it in February of 2014. Immunization Hotline was contacted to ask about any side effects or adverse effects. They stated that any of them that the patient would need to be made aware of are listed of the VIS that the patient already received.
Age: 31.0
Sex: F
Vaccine: MMR, VARZOS
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: Wrong vaccine given. Patient was expecting varicella and was given zoster (shingles). No adverse or localized reaction.
Age: 0.17
Sex: M
Vaccine: DTAPIPVHIB
Symptoms: Sudden death
Clinical narrative: He died unexpectedly and without cause according to coroner report.
Age: 68.0
Sex: F
Vaccine: VARZOS
Symptoms: Pruritus
Clinical narrative: Patient said after receiving the vaccine, the next day she had itchiness on her body.
Age: 4.0
Sex: M
Vaccine: DTAPIPV, HEPA, MMR, VARCEL
Symptoms: Injection site erythema, Injection site induration, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Immunization were administered at the doctors office at there wellness appointment. After leaving office later on that afternoon left upper arm started showing redness, swelling, feverish, hardness and tenderness. Mom called on the symptoms and was told to give him some Advil or Tylenol and Benadryl and observe it. If swelling and redness did not go away to bring him in to the office for us to check it or ER if worsen over night.  Mom brought in to the office the next day and the redness and swollenness had spread from the day before.
Age: 92.0
Sex: F
Vaccine: PNC13
Symptoms: Injection site erythema, Injection site inflammation
Clinical narrative: Red inflamed skin at injection site. Required antibiotics for 7 days.
Age: 32.0
Sex: M
Vaccine: DTAP
Symptoms: Arthralgia, Chills, Headache, Influenza like illness, Malaise
Clinical narrative: Patient reports a generalized feeling of being unwell, similar to flu like symptoms. Has fever, chills, nausea, severe HA, and arthralgia.
Age: 32.0
Sex: M
Vaccine: DTAP
Symptoms: Nausea, Pyrexia
Clinical narrative: Patient reports a generalized feeling of being unwell, similar to flu like symptoms. Has fever, chills, nausea, severe HA, and arthralgia.
Age: 67.0
Sex: M
Vaccine: PNC13
Symptoms: Injection site erythema, Pain in extremity
Clinical narrative: Pt complained of arm pain, some reddened at injection site. pt was treated with naproxen, she was monitored after 2 days, improvement noted.
Age: 1.25
Sex: M
Vaccine: DTAP, HIBV, PNC13
Symptoms: Eye swelling, Generalised erythema, Lip swelling, Pruritus, Urticaria
Clinical narrative: ENTIRE BODY TURNED RED, BROKE OUT IN HIVES ALL OVER BODY, ITCHY, SWELLING TO LIPS AND EYES. 5 ML BENADRYL GIVEN ORALLY, SYMPTOMS DECREASED WITHIN 1 HOUR AND GRADUALLY IMPROVED THROUGHOUT DAY.
Age: 29.0
Sex: F
Vaccine: TYP
Symptoms: Diarrhoea, Myalgia, Nausea, Pyrexia, Retching
Clinical narrative: Severe nausea; retching, approximately 3 episodes of vomiting. Cyclic pyrexia until early AM of 4/12; myalgia. Loose, watery stool began afternoon of 4/11; ceased by morning of 4/12. Intermittent nausea through evening of 4/12.
Age: 29.0
Sex: F
Vaccine: TYP
Symptoms: Vomiting
Clinical narrative: Severe nausea; retching, approximately 3 episodes of vomiting. Cyclic pyrexia until early AM of 4/12; myalgia. Loose, watery stool began afternoon of 4/11; ceased by morning of 4/12. Intermittent nausea through evening of 4/12.
Age: 0.75
Sex: M
Vaccine: DTAPHEPBIP
Symptoms: Injection site erythema, Vaccination site rash, Vaccination site warmth
Clinical narrative: Red spots around vaccination site and hot to touch.
Age: 58.0
Sex: F
Vaccine: PNC13
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: Patient reported to pharmacy that she woke up experiencing high fever (103 degrees) as well as soreness in the injection arm. Patient is self treating with antipyretics and analgesics and will seek treatment from a physician if incomplete resolution within a reasonable time.
Age: 6.0
Sex: M
Vaccine: DTAPHEPBIP, HEPA, MMR, VARCEL
Symptoms: Rash generalised, Rash maculo-papular
Clinical narrative: Full body maculopapular rash.
Age: 24.0
Sex: F
Vaccine: MNQ
Symptoms: Rash
Clinical narrative: Rash.
Age: 0.17
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV1
Symptoms: Decreased appetite, Emotional distress, Irritability
Clinical narrative: 2.3 days after immunizations very fussy, inconsolable, decreased appetite. UOP good, BM good, no red streaks to legs and not hot to the touch. No rashes.
Age: 23.0
Sex: M
Vaccine: TDAP
Symptoms: No adverse event
Clinical narrative: 23 year old male here at medical center to in-process on today. Patient states that he received DTaP as a child and he went into shock and was hospitalized. Patient received Tdap on today at 0810. Patient was monitored for 2 hours (Time 1010) and was released with no adverse reactions noted. Patient was instructed to go to the nearest ER if he started to have any adverse reactions such as shortness of breath develop and have hives or rash, swelling, and itching. Patient verbalized understanding.
Age: 21.0
Sex: F
Vaccine: MMR, VARCEL
Symptoms: Injection site erythema, Injection site pruritus
Clinical narrative: Pt. received MMR and Varicella on 4/6/17. On 4/8/17 noticed redness and itching to both sites - she took Ibuprofen at time. She was seen today 4-12-17 by RN at Clinic. Redness remains to both arms but no itching and pt. relays both arms are feeling much better.
Age: 0.33
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13
Symptoms: Rash
Clinical narrative: Rash on legs.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Patient developed shingles after receiving vaccine 8/31/2016.
Age: 0.17
Sex: F
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV5
Symptoms: Pallor, Rash macular
Clinical narrative: Rash several minutes after vaccination. Rash was blanching small macular lesions. BENADRYL 12.5 mg/5 ml. 2 ml x 1 dose given by mother at clinic.
Age: 25.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site swelling, Local reaction
Clinical narrative: 2 cm x 1 cm red raised area at injection site - (Local Reaction). Tx with hot compresses several times a day.
Age: 18.0
Sex: F
Vaccine: HEPA, HPV9, VARCEL
Symptoms: Injection site erythema, Injection site pain, Injection site reaction, Rash pruritic
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act (VAERS # 573471) on 04-APR-2017. This spontaneous report was received from a regulatory authority concerning a 18 year old female patient. The patient's historical condition included allergic to MENACTRA vaccine. The patient had no current illnesses. On 04-MAR-2015, the patient was vaccinated with GARDASIL 9 dose number 2, lot/batch # K009202, dose, frequency and lot expiration date was not reported) intramuscularly in the right arm for prophylaxis, VAQTA (dose number: 1, lot # K005958, dose and lot expiration date was not reported) and VARIVAX (dose number: 2, lot # K005958, dose and lot expiration date was not reported) for prophylaxis. On the same day, the patient experienced injection site erythema (left Deltoid with 3cm x 6cm oval erythematous area; tender to touch), rash pruritic (good range of motion (ROM) of arm and shoulder), injection site reaction and injection site pain. The outcome of injection site erythema, rash pruritic, injection site reaction and injection site pain was reported as recovered. Causality assessment was not reported. Additional information is not expected from the Agency as follow up information cannot be obtained.
Sex: F
Vaccine: HPV9
Symptoms: Chest discomfort, Confusional state, Dizziness, Dyspnoea, Headache
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act (VAERS # 574744) on 04-APR-2017. This spontaneous report was received from a regulatory authority refers to a 23 year old female patient. The patient's historical conditions included allergic to penicillin and sulfa drugs. The patient's current illnesses, pertinent medical history and prior vaccinations were not reported. On 15-APR-2015, the patient was vaccinated with GARDASIL 9 (lot number, dose number, dose, frequency and route of administration were not reported) for prophylaxis. On 15-APR-2015, the patient experienced tightness in chest, swollen throat, swollen tongue, pyrexia, body pain, nausea, muscular weakness, headache, difficulty breathing, dizziness and confusional state. The patient required an emergency room visit. The outcome of chest discomfort, swollen tongue, pyrexia, pharyngeal oedema, pain, nausea, muscular weakness, headache, dyspnoea, dizziness and confusional state was reported as not recovered. Causality assessment was not reported. Additional information is not expected from the Agency as follow up information cannot be obtained.
Sex: F
Vaccine: HPV9
Symptoms: Muscular weakness, Nausea, Pain, Pharyngeal oedema, Pyrexia
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act (VAERS # 574744) on 04-APR-2017. This spontaneous report was received from a regulatory authority refers to a 23 year old female patient. The patient's historical conditions included allergic to penicillin and sulfa drugs. The patient's current illnesses, pertinent medical history and prior vaccinations were not reported. On 15-APR-2015, the patient was vaccinated with GARDASIL 9 (lot number, dose number, dose, frequency and route of administration were not reported) for prophylaxis. On 15-APR-2015, the patient experienced tightness in chest, swollen throat, swollen tongue, pyrexia, body pain, nausea, muscular weakness, headache, difficulty breathing, dizziness and confusional state. The patient required an emergency room visit. The outcome of chest discomfort, swollen tongue, pyrexia, pharyngeal oedema, pain, nausea, muscular weakness, headache, dyspnoea, dizziness and confusional state was reported as not recovered. Causality assessment was not reported. Additional information is not expected from the Agency as follow up information cannot be obtained.
Sex: F
Vaccine: HPV9
Symptoms: Swollen tongue
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act (VAERS # 574744) on 04-APR-2017. This spontaneous report was received from a regulatory authority refers to a 23 year old female patient. The patient's historical conditions included allergic to penicillin and sulfa drugs. The patient's current illnesses, pertinent medical history and prior vaccinations were not reported. On 15-APR-2015, the patient was vaccinated with GARDASIL 9 (lot number, dose number, dose, frequency and route of administration were not reported) for prophylaxis. On 15-APR-2015, the patient experienced tightness in chest, swollen throat, swollen tongue, pyrexia, body pain, nausea, muscular weakness, headache, difficulty breathing, dizziness and confusional state. The patient required an emergency room visit. The outcome of chest discomfort, swollen tongue, pyrexia, pharyngeal oedema, pain, nausea, muscular weakness, headache, dyspnoea, dizziness and confusional state was reported as not recovered. Causality assessment was not reported. Additional information is not expected from the Agency as follow up information cannot be obtained.
Age: 15.0
Sex: M
Vaccine: HPV9
Symptoms: Seizure like phenomena
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act (VAERS # 578742) on 04-APR-2017. This spontaneous report was received from a regulatory authority concerning a 15 year old male patient. The patient's concurrent illness, pertinent medical history, prior vaccinations were not reported. The patient had no prior reactions noted on any vaccines. On 19-MAY-2015, the patient was vaccinated with GARDASIL 9 dose number: 3, lot # L001312 (dose, frequency and lot expiration date were not reported) in the left arm for prophylaxis. On 19-MAY-2015, the patient experienced seizure like phenomena only on left side lasting for 20 seconds. The outcome of seizure like phenomena was reported as recovered/resolved. Causality assessment was not reported. Additional information is not expected from the Agency as follow up information cannot be obtained.
Sex: F
Vaccine: HEPA, HPV9, MNQ
Symptoms: Erythema, Peripheral swelling, Pruritus
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act (VAERS # 579210). This spontaneous report refers to a 14 year old female patient. The patient's concurrent illnesses and medical history were reported as none. On 21-MAY-2015 the patient was vaccinated with GARDASIL 9 lot # L001312, dose 2, intramuscularly in the left arm and VAQTA, lot# K023870, dose 2, intramuscularly in the right arm for prophylaxis. On the same day, the patient was vaccinated with MENACTRA (lot# U4986CA, dose 2, intramuscularly in right arm). On 22-MAY-2015, the patient experienced erythema, pruritus and peripheral swelling. Right arm is red, slight swollen and itchy and no other concerns. Patient's mother applied ice pack and BENADRYL OTC, when necessary (prn). Patient was suggested to call back if worsens or no improvement by 24hrs. The outcome of erythema, pruritus and peripheral swelling were reported as recovered. Causality assessment was not provided. Additional information is not expected from the Agency as follow up information cannot be obtained.
Sex: M
Vaccine: HPV9
Symptoms: Blood glucose normal, Dizziness, Immediate post-injection reaction, Loss of consciousness
Clinical narrative: dizziness; loss of consciousness; blood glucose normal; This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act (VAERS # 580839). This spontaneous report refers to a 12 year old male patient. The patient's concurrent illnesses and medical history were not reported. On 29-MAY-2015 at approximately 11:45 am, the patient was vaccinated with GARDASIL 9 lot # L001312 dose 1, intramuscularly in the right arm for prophylaxis. On 29-MAY-2015, the patient experienced dizziness, blood glucose normal and loss of consciousness. Immediately after injection was given patient began to complain of dizziness then passed out. Per patient's mother, patient began to come to after a few seconds. Patient was monitored and vitals were taken. Patient reported that he was feeling better within a few minutes. Around 12:15 pm on 29-MAY-2015 patient reported that he felt like "he might get lightheaded". EMS was contacted at that time and patient transported to the emergency room. Patient discharged from ER same day. On 29-MAY-2015, glucose results was 102 mg/dl (normal). Patient's mother contacted to office on 30-MAY-2015, advised to staff that the patient was doing better. Other medication included immunotherapy (allergy) injections. The outcome of dizziness, blood glucose normal and loss of consciousness were reported as not recovered. Causality assessment was not provided. Additional information is not expected from the Agency as follow up information cannot be obtained.
Sex: F
Vaccine: HPV9
Symptoms: Fatigue, Headache, Pain
Clinical narrative: This report was identified from a line listing obtained on request by the Company from the FDA under the Freedom of Information Act (VAERS # 581144). This spontaneous report refers to a 11 year old female patient. The patient's concurrent illnesses included allergies and medical history included seasonal allergies. On 08-JUN-2015 the patient was vaccinated with GARDASIL 9, dose 3, intramuscularly in the left arm for prophylaxis. On 09-JUN-2015, the patient experienced fatigue, pain and headache. Severe, stabbing pain in head near temple area. Not sinus pressure like usual with allergies, but stabbing headache. Very fatigued and achy. The outcome of fatigue, pain and headache was unknown. Causality assessment was not provided. Additional information is not expected from the Agency as follow up information cannot be obtained.